• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱疼痛综合征/间质性膀胱炎的前驱期和非前驱期表型

Prodrome and Non-prodrome Phenotypes of Bladder Pain Syndrome/Interstitial Cystitis.

作者信息

Warren John W, Jian Ningbo, Gallicchio Lisa, Wu David, Clauw Daniel J

机构信息

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD.

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD.

出版信息

Urology. 2018 Aug;118:52-58. doi: 10.1016/j.urology.2018.05.004. Epub 2018 Jun 27.

DOI:10.1016/j.urology.2018.05.004
PMID:29775697
Abstract

OBJECTIVE

To test the hypothesis that risk factors for bladder pain syndrome/interstitial cystitis (BPS/IC) in women differ between those with and without the BPS/IC prodrome.

MATERIALS AND METHODS

Incident cases of BPS/IC and healthy controls were recruited nationally. More than half the BPS/IC cases reported subsyndromal urinary symptoms for decades before onset of BPS/IC and were identified as having the prodrome. Risk factors for BPS/IC were examined separately for cases with and without the prodrome using a set of matched controls.

RESULTS

Two risk factors distinguished 178 prodrome from 134 non-prodrome cases. One was "UTIs" in the year before BPS/IC onset, possibly a manifestation of the prodrome itself. The other was the presence of the maximal number of nonbladder syndromes (NBSs): prodrome cases were 12 times more likely than non-prodrome cases to have ≥4 NBSs. Additional risk factors for prodrome and/or non-prodrome cases were the direct association of exogenous female hormones, as well as 3 inverse associations: type 2 diabetes mellitus, multiple pregnancies, and current daily smoking.

CONCLUSION

Prodrome cases developed urinary symptoms in their early 20s (ie, the prodrome) and were at very high risk of numerous NBSs. Non-prodrome cases developed urinary symptoms in their early 40s (ie, full-blown BPS/IC) and were no more likely than controls to have the maximal number of NBSs. These findings are consistent with recent suggestions of two BPS/IC phenotypes: one with systemic and psychosocial manifestations and the other more specific to the bladder. Additionally, several risk factors identified here might be hints of related or causal nervous system pathophysiologies.

摘要

目的

检验以下假设,即患有膀胱疼痛综合征/间质性膀胱炎(BPS/IC)前驱症状的女性与未患该前驱症状的女性相比,BPS/IC的危险因素存在差异。

材料与方法

在全国范围内招募BPS/IC的新发病例和健康对照。超过一半的BPS/IC病例在BPS/IC发病前数十年就报告有亚综合征性泌尿系统症状,并被确定为患有前驱症状。使用一组匹配的对照,分别对有和无前驱症状的病例进行BPS/IC危险因素的检查。

结果

两个危险因素区分了178例有前驱症状的病例和134例无前驱症状的病例。一个是在BPS/IC发病前一年出现“尿路感染”,这可能是前驱症状本身的一种表现。另一个是存在最大数量的非膀胱综合征(NBSs):有前驱症状的病例出现≥4种NBSs的可能性是无前驱症状病例的12倍。前驱症状和/或无前驱症状病例的其他危险因素包括外源性女性激素的直接关联,以及3种反向关联:2型糖尿病、多次妊娠和当前每日吸烟。

结论

有前驱症状的病例在20岁出头时(即前驱症状期)出现泌尿系统症状,并且有很高的风险出现多种NBSs。无前驱症状的病例在40岁出头时(即典型的BPS/IC)出现泌尿系统症状,并且出现最大数量NBSs的可能性并不比对照组高。这些发现与最近关于BPS/IC两种表型的观点一致:一种具有全身和心理社会表现,另一种更局限于膀胱。此外,这里确定的几个危险因素可能暗示了相关或因果性的神经系统病理生理学。

相似文献

1
Prodrome and Non-prodrome Phenotypes of Bladder Pain Syndrome/Interstitial Cystitis.膀胱疼痛综合征/间质性膀胱炎的前驱期和非前驱期表型
Urology. 2018 Aug;118:52-58. doi: 10.1016/j.urology.2018.05.004. Epub 2018 Jun 27.
2
Urinary symptoms as a prodrome of bladder pain syndrome/interstitial cystitis.以尿路症状为首发表现的膀胱疼痛综合征/间质性膀胱炎。
Urology. 2014 May;83(5):1035-40. doi: 10.1016/j.urology.2014.01.012. Epub 2014 Mar 25.
3
Before the onset of interstitial cystitis/bladder pain syndrome, the presence of multiple non-bladder syndromes is strongly associated with a history of multiple surgeries.在间质性膀胱炎/膀胱疼痛综合征发作之前,存在多种非膀胱综合征与多次手术史密切相关。
J Psychosom Res. 2014 Jan;76(1):75-9. doi: 10.1016/j.jpsychores.2013.10.013. Epub 2013 Nov 1.
4
Functional somatic syndromes as risk factors for hysterectomy in early bladder pain syndrome/interstitial cystitis.功能性躯体综合征作为早期膀胱疼痛综合征/间质性膀胱炎患者子宫切除术的危险因素。
J Psychosom Res. 2014 Nov;77(5):363-7. doi: 10.1016/j.jpsychores.2014.09.004. Epub 2014 Sep 16.
5
Childhood trauma perpetrated by close others, psychiatric dysfunction, and urological symptoms in patients with interstitial cystitis/bladder pain syndrome.间质性膀胱炎/膀胱疼痛综合征患者遭受亲密他人的童年创伤、精神功能障碍和泌尿系统症状。
J Psychosom Res. 2017 Feb;93:90-95. doi: 10.1016/j.jpsychores.2016.12.014. Epub 2016 Dec 27.
6
A nationwide population-based study on bladder pain syndrome/interstitial cystitis and ED.一项基于全国人口的膀胱疼痛综合征/间质性膀胱炎和 ED 的研究。
Int J Impot Res. 2013 Nov-Dec;25(6):224-8. doi: 10.1038/ijir.2013.15. Epub 2013 Apr 4.
7
Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls.女性膀胱疼痛综合征/间质性膀胱炎患者及对照者疼痛表型的映射。
Eur Urol. 2012 Dec;62(6):1188-94. doi: 10.1016/j.eururo.2012.05.023. Epub 2012 May 18.
8
Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome.膀胱疼痛综合征/间质性膀胱炎作为一种功能性躯体综合征。
J Psychosom Res. 2014 Dec;77(6):510-5. doi: 10.1016/j.jpsychores.2014.10.003. Epub 2014 Oct 14.
9
Temporal ordering of interstitial cystitis/bladder pain syndrome and non-bladder conditions.间质性膀胱炎/膀胱疼痛综合征与非膀胱疾病的时间顺序。
Urology. 2012 Dec;80(6):1227-31. doi: 10.1016/j.urology.2012.06.059.
10
Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.间质性膀胱炎/膀胱疼痛综合征患者膀胱上皮细胞外植体中的异常Akt信号传导可通过对正常膀胱细胞进行抗增殖因子处理来诱导。
BJU Int. 2016 Jul;118(1):161-72. doi: 10.1111/bju.13457. Epub 2016 Mar 29.

引用本文的文献

1
Interstitial cystitis-an imbalance of risk and protective factors?间质性膀胱炎——风险与保护因素的失衡?
Front Pain Res (Lausanne). 2024 May 9;5:1405488. doi: 10.3389/fpain.2024.1405488. eCollection 2024.
2
The Enigma of Prodromes in Hereditary Angioedema (HAE).遗传性血管性水肿(HAE)前驱症状的谜团。
Clin Rev Allergy Immunol. 2021 Aug;61(1):15-28. doi: 10.1007/s12016-021-08839-4. Epub 2021 Feb 3.